Michael T Lynch, MD - Medicare Emergency Medicine in Concord, NH

Michael T Lynch, MD is a medicare enrolled "Emergency Medicine" physician in Concord, New Hampshire. He went to University Of Virginia School Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Dartmouth-hitchcock Clinic and his current practice location is 250 Pleasant St Er Dept, Concord, New Hampshire. You can reach out to his office (for appointments etc.) via phone at (603) 227-7000.

Michael T Lynch is licensed to practice in New Hampshire (license number 9966) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1922041094.

Contact Information

Michael T Lynch, MD
250 Pleasant St Er Dept,
Concord, NH 03301
(603) 227-7000
(603) 230-7218



Physician's Profile

Full NameMichael T Lynch
GenderMale
SpecialityEmergency Medicine
Experience31 Years
Location250 Pleasant St Er Dept, Concord, New Hampshire
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Michael T Lynch attended and graduated from University Of Virginia School Of Medicine in 1993
  NPI Data:
  • NPI Number: 1922041094
  • Provider Enumeration Date: 06/14/2006
  • Last Update Date: 09/11/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 3870554397
  • Enrollment ID: I20041019000778

Medical Identifiers

Medical identifiers for Michael T Lynch such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1922041094NPI-NPPES
30205702MedicaidNH

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 9966 (New Hampshire)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Alice Peck Day Memorial HospitalLebanon, NHHospital
Mary Hitchcock Memorial HospitalLebanon, NHHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Dartmouth-hitchcock Clinic41835375091139

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael T Lynch allows following entities to bill medicare on his behalf.
Entity NameMary Hitchcock Memorial Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023092053
PECOS PAC ID: 4486561164
Enrollment ID: O20031126000258

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more Medical News

› Verified 9 days ago

Entity NameThe New London Hospital Association Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831200583
PECOS PAC ID: 5294643623
Enrollment ID: O20040713000500

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more Medical News

› Verified 9 days ago

Entity NameDartmouth-hitchcock Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548210198
PECOS PAC ID: 4183537509
Enrollment ID: O20040809000442

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more Medical News

› Verified 9 days ago

Entity NameAlice Peck Day Memorial Hospital
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1003803495
PECOS PAC ID: 6103737531
Enrollment ID: O20061104000184

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael T Lynch is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Michael T Lynch, MD
250 Pleasant St Emergency Dept,
Concord, NH 03301-7539

Ph: (603) 277-7000
Michael T Lynch, MD
250 Pleasant St Er Dept,
Concord, NH 03301

Ph: (603) 227-7000

News Archive

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

Femtogenix announces new data on ADCs containing reduced potency payloads in solid tumor models

Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate payloads, today announced data demonstrating the potent efficacy and favorable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumor models.

Canada's Minister of Health announces Strategy for Patient-Oriented Research

Today the Honourable Leona Aglukkaq, Minister of Health announced the Strategy for Patient-Oriented Research (SPOR), a transformative research initiative that places patients at the centre of health care.

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

New drug for treating liver parasites in vivax malaria

Vivax malaria is a serious illness with high fever that, if untreated, can keep people bed-ridden for weeks or even months. But even after successful treatment, it's tricky: although the current, commonly-used drugs successfully treat the blood stage of vivax malaria, they are unable to prevent malaria parasites from invading the liver (liver stage) and causing the disease to recur repeatedly over many years.

Read more News

› Verified 9 days ago


Emergency Medicine Doctors in Concord, NH

Miss Kelsey Rainie, ATC, LAT
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 10 Avon St, Concord, NH 03301
Phone: 603-848-1859    
Zea Larochelle, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-227-7000    Fax: 603-230-7218
Ryan J. Sault, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-225-2711    Fax: 603-224-6527
Dr. Christina Gale Loporcaro, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-225-2711    Fax: 603-224-6527
Dr. Jeremy Semeiks, M.D. PH.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-225-2711    Fax: 603-224-6527
Shayna J. Carp, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant St, Concord, NH 03301
Phone: 603-225-2711    Fax: 603-224-6527
Dr. Fred P. Dutton, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 250 Pleasant Street, Emergency Department, Concord, NH 03301
Phone: 603-225-2711    Fax: 603-224-6527

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.